Bumping this for an answer to my question 
Krillin thinks so. 
That is a misreading of what I wrote. VespeneGas was asking about MTHFR, not DHFR. Only 5-MTHF bypasses the former, while both it and folinic acid bypass the latter. Bypassing DHFR prevents unmetabolized folic acid from getting into circulation, while bypassing MTHFR is pretty pointless, since folates go through the MTHFR enzyme many many times during their long biological lifetimes. The MTHFR polymorphism causes the MTHFR cofactor vitamin B2 to not stick very well, and is treatable with small doses of B2.
The real reason that 5-MTHF is preferable over folinic acid is that the Metafolin brand is chirally pure, while the folinic acid on the market is racemic. (LEF's 5-MTHF, however, appears to be racemic based on their product label.)
Here is the best methylation diagram I've encountered.
http://www.lipidworl...5/1/1/figure/F1I think a folate target of 18-23 nM looks reasonable (PMID: 9758112).
Although we failed to find a significant relationship between serum folate and all-cause mortality and circulatory disease, plots of the log relative hazard and serum folate concentration suggested a J-shaped relationship between the risk of disease and serum folate concentration with the lowest risk occurring around serum folate concentrations of 18-23 nmol/l.
That's 7.9-10.2 ng/ml, which is about the
80th-90th percentile. Which corresponds to
400-475 mcg/day. The RDA isn't so bad after all. My apologies to Michael for doubting him on this.